Intriguingly, prostate-specific IL-6 transgenic mice exhibit, in addition to autonomously induced IL-6/STAT3/IGF signaling axis-mediated prostate neoplasms, an amplification of PPAT inflammation [322]. Here, IGF1 is linked to prostate neoplasm.